Spike Pharmaceuticals and its products won the annual "War Epidemic Double Star"
Release time:
2020-07-31
News from our newspaper Recently, the results of the public welfare selection activity of 2020 Pharmaceutical Industry "Epidemic Star " were announced. Zhejiang Jianfeng Pharmaceutical Company and its products Penciclovir for Injection were also selected as "Epidemic Double Star " of the Year.
Since the outbreak of the new coronary pneumonia epidemic, Chinese pharmaceutical companies have shown their due commitment and dedication to the prevention and control of the epidemic, donating money and materials, developing drugs and developing vaccines. In order to bear in mind the enterprises that have made outstanding contributions in the epidemic prevention and control war, 4 August 24 , the public welfare selection activity of 2020 pharmaceutical industry "epidemic star " sponsored by the medical observer newspaper was officially opened, which lasted for more than a month, the 10 2020 "World Epidemic Star " most socially responsible pharmaceutical enterprises and 10 2020 "World Epidemic Star " BRICS were selected respectively.
As a socially responsible listed company, Sharp Group takes "Moral Responsibility to Help the World " as its corporate tenet, and at the beginning of the outbreak, it took the initiative to support the prevention and control of the epidemic. According to incomplete statistics, Jianfeng Pharmaceutical and its subordinate enterprises donated cash 70 yuan to medical institutions in Jinhua, Anhui and other places through various channels, as well as medical supplies such as protective clothing, gloves, medical masks and disinfectants. In addition to targeted donations to medical institutions, at the beginning of the outbreak, the majority of employees of Peak Pharmaceuticals and its affiliated Jinhua Pharmaceutical Company and Peak Pharmacy gave up rest and organized the purchase of masks, alcohol, thermal guns, disinfectants, protective clothing and other epidemic prevention supplies through various channels.
Penciclovir for injection, a product of Jianfeng Pharmaceutical Co., Ltd., is the latest dosage form of ring-opening nucleoside anti-herpes virus drugs. It only works on virus-infected cells in vivo, and is effective on various viruses. It has the characteristics of fast onset, long half-life and small side effects. Because of its excellent performance, during the outbreak, Hubei and other regions have increased procurement efforts, and was included in the "Henan Province new coronavirus infection pneumonia prevention and control work drug industry guarantee list (second phase)."
This "Epidemic Star " selection activity also received strong support from China Medical Materials Association, National Health Industry Enterprise Management Association, China Medical Quality Management Association, China Traditional Chinese Medicine Association, National Medical Elite Club and other organizations, as well as extensive support from today's headlines, Sohu Health, Sina Health, the pharmaceutical industry, many WeChat public platforms and other media, it has received extensive attention and participation from people from all walks of life. (Fang Wen Tong)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page